1. Home
  2. MRVI vs CPZ Comparison

MRVI vs CPZ Comparison

Compare MRVI & CPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • CPZ
  • Stock Information
  • Founded
  • MRVI 2014
  • CPZ 2019
  • Country
  • MRVI United States
  • CPZ United States
  • Employees
  • MRVI 560
  • CPZ N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • CPZ Trusts Except Educational Religious and Charitable
  • Sector
  • MRVI Health Care
  • CPZ Finance
  • Exchange
  • MRVI Nasdaq
  • CPZ Nasdaq
  • Market Cap
  • MRVI 350.1M
  • CPZ 328.3M
  • IPO Year
  • MRVI 2020
  • CPZ N/A
  • Fundamental
  • Price
  • MRVI $2.42
  • CPZ $16.72
  • Analyst Decision
  • MRVI Hold
  • CPZ
  • Analyst Count
  • MRVI 10
  • CPZ 0
  • Target Price
  • MRVI $5.84
  • CPZ N/A
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • CPZ 63.0K
  • Earning Date
  • MRVI 08-11-2025
  • CPZ 01-01-0001
  • Dividend Yield
  • MRVI N/A
  • CPZ 11.07%
  • EPS Growth
  • MRVI N/A
  • CPZ N/A
  • EPS
  • MRVI N/A
  • CPZ N/A
  • Revenue
  • MRVI $219,830,000.00
  • CPZ N/A
  • Revenue This Year
  • MRVI N/A
  • CPZ N/A
  • Revenue Next Year
  • MRVI $7.23
  • CPZ N/A
  • P/E Ratio
  • MRVI N/A
  • CPZ N/A
  • Revenue Growth
  • MRVI N/A
  • CPZ N/A
  • 52 Week Low
  • MRVI $1.67
  • CPZ $13.17
  • 52 Week High
  • MRVI $9.60
  • CPZ $16.11
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • CPZ 60.18
  • Support Level
  • MRVI $2.28
  • CPZ $16.50
  • Resistance Level
  • MRVI $2.47
  • CPZ $16.70
  • Average True Range (ATR)
  • MRVI 0.14
  • CPZ 0.18
  • MACD
  • MRVI -0.01
  • CPZ 0.00
  • Stochastic Oscillator
  • MRVI 27.45
  • CPZ 81.40

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About CPZ Calamos Long/Short Equity & Dynamic Income Trust

Calamos L/S Equity & Dynamic Inc Trust is a trust company which seeks to provide current income and risk-managed capital appreciation. The company invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary and others.

Share on Social Networks: